Serum levels of sex hormones before and after androgen deprivation therapy in Japanese prostate cancer patients

被引:0
|
作者
Komiya, A. [1 ]
Ichimatsu, K. [1 ]
Morii, A. [1 ]
Watanabe, A. [1 ]
Fuse, H. [1 ]
机构
[1] Toyama Univ, Dept Urol, Grad Sch Med & Pharmaceut Sci Res, Toyama 930, Japan
关键词
TESTOSTERONE;
D O I
暂无
中图分类号
R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
摘要
We investigated the relationship between treatment outcomes and serum levels of sex hormones before and after androgen deprivation therapy (ADT) in 147 Japanese Prostate cancer (PCa) patients. Sex hormones including total testosterone (TST). estradiol (E2), and prolactin (PRL) were measured before and 4 weeks after initiation of ADT. Pretreatment levels of PRL were higher in high grade PCa (P=0.0397). Serum levels of TST and E2 or TST/E2 ratio were significantly lowered after 4 weeks of ADT. However. serum PRL was increased after ADT. Serum levels of sex hormones after ADT differed by the type of antiandrogens. PSA response for ADT was related to initial PSA levels. PRL after ADT, E2 after ADT, clinical stages and pathological grades. Multivariate analysis determined serum PRL before ADT and after ADT, pathological grades and initial PSA as the independent prognostic factors of cause specific survival in PCa with ADT.
引用
收藏
页码:135 / 138
页数:4
相关论文
共 50 条
  • [21] Androgen Deprivation Therapy for Prostate Cancer
    Pagliarulo, Vincenzo
    MOLECULAR & DIAGNOSTIC IMAGING IN PROSTATE CANCER: CLINICAL APPLICATIONS AND TREATMENT STRATEGIES, 2019, 1126 : 1 - 30
  • [22] Androgen deprivation therapy for prostate cancer
    Das, Manjulika
    LANCET ONCOLOGY, 2017, 18 (10): : E567 - E567
  • [23] Immunohistochemical changes in prostate cancer after androgen deprivation therapy
    Bostwick, DG
    MOLECULAR UROLOGY, 2000, 4 (03) : 101 - 106
  • [24] Androgen deprivation therapy for prostate cancer
    Sharifi, N
    Gulley, JL
    Dahut, WL
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (02): : 238 - 244
  • [25] Androgen deprivation therapy for prostate cancer
    Bahnson, Robert
    JOURNAL OF UROLOGY, 2007, 178 (04): : 1148 - 1148
  • [26] Androgen deprivation therapy for prostate cancer
    Singer, Eric A.
    Golijanin, Dragan J.
    Miyamoto, Hiroshi
    Messing, Edward M.
    EXPERT OPINION ON PHARMACOTHERAPY, 2008, 9 (02) : 211 - 228
  • [27] Prevalence of hand joint symptoms in androgen deprivation therapy among japanese patients with prostate cancer
    Inoue, Shogo
    Hayashi, Tetsutaro
    Teishima, Jun
    Matsubara, Akio
    UROLOGICAL SCIENCE, 2020, 31 (01) : 15 - 20
  • [28] Androgen deprivation therapy duration is significantly associated with Testosterone recovery in Japanese patients with prostate cancer
    Arai, Masashi
    Kosaka, Takeo
    Yasumizu, Yota
    Takeda, Toshikazu
    Matsumoto, Kazuhiro
    Oya, Mototsugu
    INTERNATIONAL JOURNAL OF UROLOGY, 2023, 30 (02) : 235 - 239
  • [29] Effect of Androgen-deprivation Therapy on Bone Mineral Density in Japanese Patients with Prostate Cancer
    Miyazawa, Yoshiyuki
    Sekine, Yoshitaka
    Syuto, Takahiro
    Nomura, Masashi
    Koike, Hidekazu
    Matsui, Hiroshi
    Shibata, Yasuhiro
    Ito, Kazuto
    Suzuki, Kazuhiro
    IN VIVO, 2018, 32 (02): : 409 - 412
  • [30] The Effects of Androgen Deprivation Therapy on Lipid Metabolism and Body Composition in Japanese Patients with Prostate Cancer
    Torimoto, Kazumasa
    Samma, Shoji
    Kagebayashi, Yoriaki
    Chihara, Yoshitomo
    Tanaka, Nobumichi
    Hirayama, Akihide
    Fujimoto, Kiyohide
    Hirao, Yoshihiko
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2011, 41 (04) : 577 - 581